ERBB2 and prostate carcinoma: In prostate cancer cell lines, resveratrol reduced the levels of several receptor tyrosin kineses (EGFR, ErbB2/HER2, IGFR-1) in a time-dependent manner, particularly in androgen-negative prostate cancer cells [79,118].